In early 2026, Moderna reported encouraging long-term data for its personalized cancer vaccine mRNA-4157 (V940) in high-risk melanoma, while the FDA granted expedited review and an August 5, 2026 ...

Combined with the administration’s erratic regulation and policymaking, it threatens to undo the salutary ecosystem that made ...

Arexvy will now compete for market share with Pfizer’s Abrysvo and Moderna’s mRESVIA in this expanded, high-risk adult ...

Few corporate cautionary tales are as vivid as the rise and fall of Moderna Inc. During the pandemic, the company’s mRNA vaccine was approved and distributed in record time, saving ...

With no biology degree and just $3,000, he designed a personalized mRNA vaccine in a world first. Moderna and Merck are ...

A federal work group says Covid vaccine injuries deserve urgent attention, even as Health Secretary Robert F. Kennedy Jr.

Few corporate cautionary tales are as vivid as the rise and fall of Moderna Inc. During the pandemic, the company’s mRNA vaccine was approved and ...

Adults aged 18 to 49 years at increased risk for RSV-associated lower respiratory tract disease are now eligible for the Arexvy vaccine.

The decision by Judge Brian Murphy immediately halted implementation of a series of measures imposed by the Trump ...

Executive chairman Patrick Soon-Shiong highlighted early immune activation data from an Anktiva study. ・Anktiva was also ...

The Food and Drug Administration has linked cheddar cheese made from raw (unpasteurized) milk to a multistate outbreak of ...

NEW YORK (AP) — As the U.S. flu season winds down, health officials say the flu vaccine didn’t work very well, with one of its worst effectiveness rates in more than a decade. A new strain that ...